News
Interdisciplinary GU Cancer Forum 2025, urothelial carcinoma, Metastatic Urothelial Carcinoma, enfortumab vedotin, advanced urothelial carcinoma when enfortumab vedotin, Optimal Sequence of Treatment ...
SNMMI 2025 radium-223-treated patients, REASSURE study, metastatic castration-resistant prostate cancer (mCRPC), ALSYMPCA trial, safety of radium-223 in patients with mCRPC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback